Issue link: https://viewer.e-digitaledition.com/i/521055
target — and movement caused by breathing is a significant change in position. Traditional delivery methods expose much more of the surrounding tissue to radiation." External LEDs enable the system to track respiratory motion, and the CyberKnife sys- tem adjusts the radiation beams accordingly. "The CyberKnife reduces margins of error associated with older technologies by essen- tially anticipating the location of the tumor," Witten says. "CyberKnife significantly reduces the probability of complications attributable to radiation toxicity, such as pneumonitis, and is an excellent option for lung tumors." Collaborative Care With its state-of-the-art facility in Manhattan, Winthrop's NYCyberKnife Center expects to impact prostate and other cancer patients' outcomes by making more treatment options available to the greater New York Metropolitan Area. The depart- ment also has the privilege to work with Aaron Katz, MD, Winthrop's Chairman of Urology, who is a world-renowned expert in prostate cancer and genitourinary malignan- cies and has provided guidance and support of the program. "Patients do travel for the best medical care, and this new center makes CyberKnife so much more accessible," Dr. Haas says. "We want to fill a void for those patients in the region and beyond who did not have the opportunity previously to be treated with CyberKnife radiosurgery technology and get them back to their lives, families, jobs and ultimately, cured." Expanding its services to Manhattan also opens the Winthrop NYCyberKnife Center's team to working with other physicians in the region who may have patients who can benefit from the capabilities of CyberKnife radiosurgery. " We t re at a w ide variety of sites such as prostate, lung, breast, liver, brain, spine, and soft tissue masses, as well as functional conditions like trigeminal neuralgia, and we can evaluate all patients to determine if treatment is appropriate," Witten says. "Our expertise extends to all cancer types," Dr. Blacksburg adds. "We have successfully treated patients for prostate cancer, breast cancer, benign and malignant tumors of the brain and spine, gastrohepatic malignancies, and other soft tissue tumors. For every treatment we perform, we always work collaboratively with the other members of the patient's medical team, including their urologists, medical oncologists, or surgical team." The Winthrop NYCyberKnife Center team is equipped to provide a level of care unmatched by more traditional radiation treatments. "We have been performing CyberKnife radiation therapies for prostate and other cancers at Winthrop-University Hospital since 2005, and it has been an absolute godsend," Dr. Haas says. "The new Winthrop NYCyberKnife Center in Manhattan serves a broader geographic area, so cancer patients from the tri-state area and beyond have easier access to advanced technology that improves outcomes." For more information about the Winthrop NYCyberKnife Center in Manhattan, visit winthrop.org. ■ The same features that make CyberKnife therapy ideal for prostate cancer treatment also indicate the modality for lung cancer therapy, Witten notes. Tumors in the prostate may shift as contents of the bowel or bladder move, so CyberKnife's motion-tracking tech- nology locks on to the tumor and provides real-time information pertaining to the target's positioning. When treating tumors in the lung, radiation oncologists have to account for movement concurrent with respiration. Traditional techniques, such as respira- tory gating, are effective, but CyberKnife's capabilities are far superior. "No other system can do what CyberKnife does in terms of compensating for the respira- tory excursion of a lung tumor," Witten says. "During the respiratory cycle, the tumor moves, which makes it a constantly moving Winthrop's NYCyberKnife Center, located at 150 Amsterdam Avenue at 66th Street, provides residents of Manhattan and the New York tri-state area with greater access to Winthrop's CyberKnife services and will serve as a worldwide training center for practitioners. Seth Blacksburg, MD, MBA, Medical Director of Winthrop NYCyberKnife Center and Associate Director of Radiation Oncology at Winthrop-University Hospital "The main advantage of CyberKnife radiosurgery is that it permits delivery of a higher ablative dose to a tumor in a much more controlled way than any other type of radiation therapy. There is nothing more fulfilling than optimizing a patient's treatment with a superior technology." —Seth Blacksburg, MD, MBA, Medical Director of Winthrop NYCyberKnife Center and Associate Director of Radiation Oncology at Winthrop-University Hospital COV ER FE AT UR E 1 0 | Lower Hudson/Bronx MD NEWS ■ M D N E W S . CO M

